Roivant Sciences Ltd.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $1.42B | $2.72B | $6.49B | $1.68B | $2.06B | $2.06B | $2.27B |
| Accounts Receivable | — | — | $53.5M | $30.4M | $3.9M | — | — |
| Inventory | — | — | $35.3M | $2.8M | $0 | — | — |
| Total Current Assets | $5.17B | $5.00B | $6.73B | $1.80B | $2.15B | $2.19B | — |
| Property, Plant & Equipment | $12.0M | $12.1M | $15.3M | $39.1M | $25.9M | $14.7M | — |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $137.8M | $144.9M | $0 | — | — |
| Total Assets | $5.71B | $5.44B | $7.22B | $2.39B | $2.59B | $2.59B | — |
| Liabilities | |||||||
| Accounts Payable | $18.0M | $23.7M | $14.0M | $37.8M | $34.6M | $20.6M | — |
| Total Current Liabilities | $281.2M | $149.4M | $266.8M | $272.4M | $184.4M | $219.0M | — |
| Long-Term Debt | — | — | $430.6M | $375.5M | $210.0M | $170.3M | — |
| Total Liabilities | $416.3M | $249.7M | $774.0M | $782.0M | $523.7M | $527.7M | — |
| Stockholders' Equity | |||||||
| Retained Earnings | $-501.8M | $116.1M | $576.2M | $-3.77B | $-2.76B | $-1.92B | — |
| Total Stockholders' Equity | $4.53B | $4.69B | $5.97B | $1.16B | $1.66B | $1.80B | $2.09B |